• About
  • Overview
  • Management
    • Dr. Joe Lewis
    • Dr. Bernd Janssen
    • Sally-Anne Watson
  • Supervisory Board
  • Scientific Advisory Board
  • Prof. Frank Giles
  • Investors
• Programs
  • Mechanism of Action
  • Technology
  • Products
  • Technology Fact Sheet
• News
  • Latest News
  • Upcoming Events
  • Download Area
• Careers
  • Vacancies
• Contact
  • Contact
• Home
  • Home

Latest News

26 November, 2009
ELARA Pharmaceuticals receives EUR 4.6 Million funding
and names Dr. Christof Antz as Chief Business Officer.
Financing supports development of lead candidate for the treatment of Multiple Myeloma and other cancers to IND.

ELARA Pharmaceuticals erhält Finanzierung in Höhe von 4,6 Millionen Euro und ernennt Dr. Christof Antz zum Chief Business Officer
Finanzmittel ermöglichen die Entwicklung eines innovativen Medikamentenkandidaten zur Behandlung des Multiplen Myeloms und anderer Krebserkrankungen bis zur Klinik.

» News Archive